TARA COMER: Open Payments
NPI 1912989427 · IRWIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,139 in 151 payments from 11 companies in 2025. Trend: 2023 $1,238 · 2024 $1,294 · 2025 $2,139
Food & beverage: $2,139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 81 | $962 |
| Otsuka America Pharmaceutical, Inc. | 17 | $326 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $226 |
| Teva Pharmaceuticals USA, Inc. | 9 | $147 |
| Vanda Pharmaceuticals Inc. | 6 | $126 |
| Neurocrine BioSciences, Inc. | 5 | $85 |
| Alkermes, Inc. | 4 | $68 |
| Janssen Pharmaceuticals, Inc | 4 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
Products named: VRAYLAR, REXULTI, CAPLYTA, FANAPT, AUSTEDO XR, INGREZZA, ARISTADA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
